We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ATRA icon
726
Atara Biotherapeutics
ATRA
$79M
$79M $8.77 2.57%
CSBR icon
727
Champions Oncology
CSBR
$75.7M
$75.7M $5.45 5.38%
SERA icon
728
Sera Prognostics
SERA
$75.6M
$75.6M $1.93 8.1%
GANX icon
729
Gain Therapeutics
GANX
$75.1M
$75.1M $1.76 0.57%
NNOX icon
730
Nano X Imaging
NNOX
$74.5M
$74.5M $1.07 2.73%
OSTX
731
OS Therapies Inc
OSTX
$74.2M
$74.2M $1.63 5.16%
DH icon
732
Definitive Healthcare
DH
$73.9M
$73.9M $0.7000 0%
IBIO icon
733
iBio
IBIO
$72.5M
$72.5M $1.46 2.82%
CRDF icon
734
Cardiff Oncology
CRDF
$72.3M
$72.3M $0.9289 0.55%
LONA
735
LeonaBio Inc
LONA
$72M
$72M $7.66 2.54%
SPRO icon
736
Spero Therapeutics
SPRO
$71.2M
$71.2M $1.23 6.96%
TLPH icon
737
Talphera
TLPH
$70.6M
$70.6M $1.36 2.26%
BTMD icon
738
Biote Corp
BTMD
$68.9M
$68.9M $2.27 0.87%
LNSR icon
739
LENSAR
LNSR
$68.5M
$68.5M $5.58 3.72%
INO icon
740
Inovio Pharmaceuticals
INO
$68.5M
$68.5M $0.6631 4.84%
XBIT icon
741
XBiotech
XBIT
$68.3M
$68.3M $2.24 0%
DRIO icon
742
DarioHealth
DRIO
$67M
$67M $6.87 3.24%
ACRV icon
743
Acrivon Therapeutics
ACRV
$66.8M
$66.8M $1.56 0%
CING icon
744
Cingulate
CING
$66M
$66M $4.90 1.45%
ALPS
745
ALPS Group Inc
ALPS
$66M
$66M $0.3964 0.13%
RNTX
746
Rein Therapeutics
RNTX
$65.3M
$65.3M $0.7637 2.44%
PLRX icon
747
Pliant Therapeutics
PLRX
$65M
$65M $1.05 0.96%
IMA
748
ImageneBio Inc
IMA
$64.9M
$64.9M $5.71 1.24%
DCGO icon
749
DocGo
DCGO
$64.4M
$64.4M $0.6523 0.62%
MNOV icon
750
MediciNova
MNOV
$64M
$64M $1.30 2.26%
28 29
30
31 32

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.